Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/MONOPAR-THERAPEUTICS-INC-66480648/noticia/Monopar-recibe-la-autorizaci-n-para-iniciar-el-primer-ensayo-en-humanos-de-fase-1-de-su-novedoso-ra-45989801/?utm_source=whatsapp&utm_medium=social&utm_campaign=share